Pancreatic Cancer Research

ResearcherTokyo Metropolitan Institute of GerontologyActive in the last 2 years

Fujiya Gomi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1510-9001; OpenAlex author ID A5069820503. Sources: OpenAlex.

Their work

Papers
11 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2019: 3 papers · 2020: 2 papers · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 11

  1. Transmission electron microscopic analysis of pancreatic ductal adenocarcinoma cell spheres formed in 3D cultures. Co-author DOI 10.1007/s00795-025-00435-1↗
  2. Artificial intelligence-based analysis of time-lapse images of sphere formation and process of plate adhesion and spread of pancreatic cancer cells. First author DOI 10.3389/fcell.2023.1290753↗
  3. Gp130-Mediated STAT3 Activation Contributes to the Aggressiveness of Pancreatic Cancer through H19 Long Non-Coding RNA Expression. Co-author DOI 10.3390/cancers14092055↗
  4. Epithelial and Mesenchymal Features of Pancreatic Ductal Adenocarcinoma Cell Lines in Two- and Three-Dimensional Cultures. First author DOI 10.3390/jpm12050746↗
  5. Polyvinyl alcohol increased growth, migration, invasion, and sphere size in the PK-8 pancreatic ductal adenocarcinoma cell line. Co-author DOI 10.1016/j.heliyon.2021.e06182↗
  6. Morphofunctional analysis of human pancreatic cancer cell lines in 2- and 3-dimensional cultures. Co-author DOI 10.1038/s41598-021-86028-1↗
  7. Characterization of the metastatic potential of the floating cell component of MIA PaCa-2, a human pancreatic cancer cell line. First author DOI 10.1016/j.bbrc.2019.11.120↗
  8. FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pan… First author DOI 10.3390/cancers12102976↗
  9. Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers. Co-author DOI 10.1016/j.bbrc.2019.04.117↗
  10. Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture. Co-author DOI 10.1038/s41598-019-47416-w↗
  11. Ganglioside GM2, highly expressed in the MIA PaCa-2 pancreatic ductal adenocarcinoma cell line, is correlated with growth, invasion, and advanced stage. Co-author DOI 10.1038/s41598-019-55867-4↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toshiyuki Ishiwata · 11 shared papers, 2019–2025 · strength 1.60
  2. Yuuki Shichi · 7 shared papers, 2019–2025 · strength 1.17
  3. Norihiko Sasaki · 9 shared papers, 2019–2022 · strength 1.15
  4. Masashi Toyoda · 8 shared papers, 2019–2022 · strength 0.97
  5. Tomio Arai · 3 shared papers, 2019–2025 · strength 0.52
  6. Masakazu Fujiwara · 3 shared papers, 2019–2025 · strength 0.49
  7. Hisashi Yoshimura · 3 shared papers, 2019–2022 · strength 0.35
  8. Fuuka Minami · 2 shared papers, 2021 · strength 0.28
  9. Yoko Matsuda · 2 shared papers, 2019–2020 · strength 0.19
  10. Akira Matsushita · 1 shared paper, 2022 · strength 0.16
  11. Murray Korc · 1 shared paper, 2020 · strength 0.11
  12. Kenichi Hirabayashi · 1 shared paper, 2019 · strength 0.09
  13. Naoya Nakamura · 1 shared paper, 2019 · strength 0.09
  14. Junko Aida · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.